Skip to main content

Montanova Capital, LLC

13F filer · CIK 0001569064
Reported Aug 14, 2026
Net buyer this quarter
13F portfolio value$5.47BU.S. long equity reported on 13F
Positions9421 new · 14 closed
Net flow last quarter+$133MBuys minus sells
Top 10 positions weight38.8%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 14, 202694 positions
MANEVeradermics, Inc$513M9.37%9.98%Not reportedQ1 2026
ARQTArcutis Biotherapeutics, Inc.$326M5.96%9.90%+0.9%Q1 2023
LEGNLegend Biotech Corp$204M3.73%1.91%-6.7%Q2 2020
PVLAPalvella Therapeutics, Inc.$174M3.17%7.89%-1.6%Q4 2024
AVBPArriVent BioPharma, Inc.$157M2.87%9.35%+2.6%Q1 2024
BNTCBenitec Biopharma Inc.$155M2.83%33.55%Not reportedQ2 2021
BHVNBiohaven Ltd.$153M2.80%6.81%Not reportedQ1 2022
AMDAdvanced Micro Devices Inc$149M2.73%0.02%Not reportedQ4 2022
RCUSArcus Biosciences, Inc.$147M2.69%3.76%-5.1%Q3 2023
TSMTaiwan Semiconductor Manufacturing Co Ltd$145M2.66%0.00%+2.0%Q2 2023
NVDANvidia Corp$144M2.64%0.00%+25.4%Q4 2022
EYPTEyePoint, Inc.$119M2.17%9.76%Not reportedQ1 2021
SYYSysco Corp$118M2.16%0.30%+21.8%Q1 2019
GEGeneral Electric Co$116M2.12%0.03%Not reportedQ2 2023
IMTXImmatics N.V.$113M2.07%8.35%Not reportedQ1 2024
MGMMGM Resorts International$111M2.03%0.92%+7.7%Q4 2025
METAMeta Platforms, Inc.$99M1.81%Not reported+3.6%Q4 2014
CAPRCapricor Therapeutics, Inc.$98.6M1.80%7.04%+7.2%Q4 2025
KURAKura Oncology, Inc.$94.1M1.72%9.64%Not reportedQ3 2020
GLUEMonte Rosa Therapeutics, Inc.$85.9M1.57%4.16%-16.0%Q2 2021
AVLNAvalyn Pharma Inc.$82.4M1.51%5.65%NewQ2 2026
HDHome Depot, Inc.$79.7M1.46%0.02%+2.0%Q4 2016
HUTHut 8 Corp.$77.3M1.41%0.54%NewQ2 2026
COFCapital One Financial Corp$66.8M1.22%0.05%+10.2%Q4 2016
VMCVulcan Materials CO$63.4M1.16%0.17%+18.4%Q1 2026
FERGFerguson Enterprises Inc.$58.6M1.07%0.13%+16.5%Q4 2023
ZURAZura Bio Ltd$55.7M1.02%9.90%+4.2%Q2 2023
IFRXInflaRx N.V.$51.4M0.94%31.72%+189.1%Q1 2021
AURAAura Biosciences, Inc.$51.2M0.94%6.96%+64.8%Q1 2025
FTHFaeth Therapeutics, Inc.$50.5M0.92%7.82%+5747.1%Q1 2026
AMZNAmazon Com Inc$48.8M0.89%0.00%-19.4%Q1 2016
REPLReplimune Group, Inc.$48.6M0.89%5.23%+4.0%Q4 2025
APHAmphenol Corp$47.5M0.87%0.02%Not reportedQ2 2020
SPOTSpotify Technology S.A.$46.7M0.85%0.05%+9154.6%Q2 2019
CTNMContineum Therapeutics, Inc.$46.6M0.85%12.30%Not reportedQ2 2024
APOApollo Global Management, Inc.$45.3M0.83%0.07%-1.1%Q3 2023
BACBank of America Corp$45M0.82%0.01%-39.0%Q1 2018
DRAMU.S. Gold Corp.$44.5M0.81%Not reportedNewQ2 2026
CRNXCrinetics Pharmaceuticals, Inc.$44.4M0.81%1.12%+13.6%Q2 2022
CBRSCerebras Systems Inc.$38M0.69%Not reportedNewQ2 2026
DKSDick'S Sporting Goods, Inc.$34.3M0.63%0.16%Not reportedQ2 2025
AVGOBroadcom Inc.$31.6M0.58%0.00%NewQ2 2026
CMPXCompass Therapeutics, Inc.$30.9M0.56%7.83%-1.4%Q2 2025
LXEOLexeo Therapeutics, Inc.$29.7M0.54%8.12%+410.7%Q4 2025
UNHUnitedhealth Group Inc$26.7M0.49%0.01%-36.3%Q4 2016
PROKProkidney Corp.$25.2M0.46%Not reportedNot reportedQ3 2022
WHWKWhitehawk Therapeutics, Inc.$19.7M0.36%7.54%+16.2%Q1 2025
SPCXSpace Exploration Technologies Corp$17.3M0.32%Not reportedNewQ2 2026
MLMMartin Marietta Materials Inc$15M0.27%0.04%NewQ2 2026
FULCFulcrum Therapeutics, Inc.$13.5M0.25%4.83%-43.9%Q1 2021
Q1 2026Reported May 15, 202687 positions
ARQTArcutis Biotherapeutics, Inc.$290M7.42%9.86%+3.0%Q1 2023
MANEVeradermics, Inc$263M6.72%11.16%NewQ1 2026
PVLAPalvella Therapeutics, Inc.$144M3.67%8.06%+29.3%Q4 2024
APLSApellis Pharmaceuticals, Inc.$142M3.62%2.75%-15.0%Q1 2020
LEGNLegend Biotech Corp$137M3.50%2.05%+14.7%Q2 2020
BNTCBenitec Biopharma Inc.$123M3.14%33.62%Not reportedQ2 2021
CAPRCapricor Therapeutics, Inc.$116M2.97%6.62%+113.9%Q4 2025
IMTXImmatics N.V.$110M2.81%8.35%Not reportedQ1 2024
RCUSArcus Biosciences, Inc.$109M2.78%4.01%-3.0%Q3 2023
EYPTEyePoint, Inc.$107M2.73%9.94%+6.0%Q1 2021
AVBPArriVent BioPharma, Inc.$102M2.59%9.71%+7.2%Q1 2024
TSMTaiwan Semiconductor Manufacturing Co Ltd$101M2.58%0.00%+10.1%Q2 2023
NVDANvidia Corp$100M2.56%0.00%+8.2%Q4 2022
METAMeta Platforms, Inc.$97.1M2.48%Not reported+0.4%Q4 2014
KALVKalVista Pharmaceuticals, Inc.$96M2.45%9.31%Not reportedQ1 2020
GEGeneral Electric Co$88M2.25%0.03%Not reportedQ2 2023
BHVNBiohaven Ltd.$87M2.22%6.83%Not reportedQ1 2022
SYYSysco Corp$82.7M2.11%0.24%+7.0%Q1 2019
MGMMGM Resorts International$79.9M2.04%0.84%+79.6%Q4 2025
CMPXCompass Therapeutics, Inc.$75.7M1.93%7.94%+0.9%Q2 2025
HDHome Depot, Inc.$72.9M1.86%0.02%-8.0%Q4 2016
KURAKura Oncology, Inc.$69.7M1.78%9.66%Not reportedQ3 2020
GLUEMonte Rosa Therapeutics, Inc.$69.5M1.78%5.01%+25.8%Q2 2021
BACBank of America Corp$63.1M1.61%0.02%-14.7%Q1 2018
ERASErasca, Inc.$55.6M1.42%1.11%-76.3%Q2 2024
COFCapital One Financial Corp$55.2M1.41%0.05%+75.8%Q4 2016
ZURAZura Bio Ltd$53.9M1.38%9.56%+62.9%Q2 2023
AMZNAmazon Com Inc$52.9M1.35%0.00%-37.5%Q1 2016
AMDAdvanced Micro Devices Inc$52.3M1.34%0.02%-34.0%Q4 2022
FULCFulcrum Therapeutics, Inc.$50.3M1.29%9.85%Not reportedQ1 2021
VMCVulcan Materials CO$49.4M1.26%0.14%NewQ1 2026
FERGFerguson Enterprises Inc.$49.4M1.26%0.11%+33.1%Q4 2023
APOApollo Global Management, Inc.$43.2M1.10%0.07%-28.6%Q3 2023
MLYSMineralys Therapeutics, Inc.$41.7M1.06%1.87%Not reportedQ1 2025
CRNXCrinetics Pharmaceuticals, Inc.$37.9M0.97%0.99%Not reportedQ2 2022
CTNMContineum Therapeutics, Inc.$37.1M0.95%12.30%Not reportedQ2 2024
USFDUS Foods Holding Corp.$36.5M0.93%0.18%Not reportedQ3 2016
PFGCPerformance Food Group Co$33.1M0.85%0.25%NewQ1 2026
REPLReplimune Group, Inc.$32.3M0.82%5.10%+11615.0%Q4 2025
AURAAura Biosciences, Inc.$29.3M0.75%6.82%Not reportedQ1 2025
UNHUnitedhealth Group Inc$27.2M0.70%0.01%-9.6%Q4 2016
PROKProkidney Corp.$22.1M0.56%Not reportedNot reportedQ3 2022
LTHLife Time Group Holdings, Inc.$13.7M0.35%0.23%NewQ1 2026
WHWKWhitehawk Therapeutics, Inc.$12.8M0.33%7.84%Not reportedQ1 2025
ABEOAbeona Therapeutics Inc.$12M0.31%4.71%Not reportedQ2 2024
WINGWingstop Inc.$9.22M0.24%0.22%Not reportedQ2 2025
MOLNMolecular Partners AG$8.82M0.23%5.50%Not reportedQ2 2021
BSXBoston Scientific Corp$7.78M0.20%0.01%-64.9%Q3 2018
LXEOLexeo Therapeutics, Inc.$7.18M0.18%1.69%Not reportedQ4 2025
COHRCoherent Corp.$7.15M0.18%0.02%-78.3%Q4 2025
Q4 2025Reported Feb 17, 202689 positions
ARQTArcutis Biotherapeutics, Inc.$347M7.12%9.70%+14.2%Q1 2023
BNTCBenitec Biopharma Inc.$156M3.19%33.71%+16.9%Q2 2021
LEGNLegend Biotech Corp$144M2.94%1.79%+73.1%Q2 2020
EYPTEyePoint, Inc.$143M2.93%9.45%+26.4%Q1 2021
RCUSArcus Biosciences, Inc.$124M2.53%4.14%+40.7%Q3 2023
IMTXImmatics N.V.$117M2.41%8.35%-7.0%Q1 2024
BHVNBiohaven Ltd.$116M2.38%7.75%+83.0%Q1 2022
METAMeta Platforms, Inc.$112M2.29%Not reported-1.1%Q4 2014
APLSApellis Pharmaceuticals, Inc.$104M2.13%3.27%+43.8%Q1 2020
NVDANvidia Corp$99M2.03%0.00%+9.8%Q4 2022
KOCoca Cola Co$96.7M1.98%0.03%-5.0%Q1 2024
GEGeneral Electric Co$95.6M1.96%0.03%Not reportedQ2 2023
AMZNAmazon Com Inc$93.7M1.92%0.00%+85.8%Q1 2016
PVLAPalvella Therapeutics, Inc.$93.4M1.91%7.21%+8.5%Q4 2024
KURAKura Oncology, Inc.$89.1M1.83%9.76%+5.7%Q3 2020
BACBank of America Corp$83.5M1.71%0.02%+30.8%Q1 2018
AMDAdvanced Micro Devices Inc$83.4M1.71%0.02%-2.3%Q4 2022
HDHome Depot, Inc.$82.9M1.70%0.02%+22.1%Q4 2016
AVBPArriVent BioPharma, Inc.$82.6M1.69%9.67%+10.9%Q1 2024
TSMTaiwan Semiconductor Manufacturing Co Ltd$82.5M1.69%0.00%-2.1%Q2 2023
SYYSysco Corp$79.9M1.64%0.23%Not reportedQ1 2019
APOApollo Global Management, Inc.$78.6M1.61%0.09%+25.9%Q3 2023
MSFTMicrosoft Corp$77.2M1.58%0.00%+45.9%Q4 2015
KALVKalVista Pharmaceuticals, Inc.$77M1.58%9.37%Not reportedQ1 2020
CMPXCompass Therapeutics, Inc.$76.2M1.56%7.95%+0.6%Q2 2025
FULCFulcrum Therapeutics, Inc.$74.2M1.52%9.85%+21.9%Q1 2021
NOWServiceNow, Inc.$59.7M1.22%0.04%+254.0%Q3 2019
DHRDanaher Corp$55.9M1.15%0.03%-4.5%Q3 2014
MLYSMineralys Therapeutics, Inc.$55.8M1.14%1.89%-27.8%Q1 2025
ERASErasca, Inc.$53.9M1.11%5.10%Not reportedQ2 2024
CRMSalesforce, Inc.$53M1.08%0.02%+59.6%Q4 2016
GLUEMonte Rosa Therapeutics, Inc.$52.7M1.08%5.13%Not reportedQ2 2021
CAPRCapricor Therapeutics, Inc.$51.5M1.06%3.11%NewQ4 2025
RAREUltragenyx Pharmaceutical Inc.$46.4M0.95%2.09%Not reportedQ4 2021
ORCLOracle Corp$44.1M0.90%0.01%Not reportedQ4 2022
MGMMGM Resorts International$43.9M0.90%0.47%NewQ4 2025
COFCapital One Financial Corp$41.7M0.85%0.03%-28.0%Q4 2016
TSLATesla, Inc.$41M0.84%0.00%Not reportedQ2 2024
UNHUnitedhealth Group Inc$36.7M0.75%0.01%+15.7%Q4 2016
FERGFerguson Enterprises Inc.$35.4M0.73%0.08%-48.0%Q4 2023
BSXBoston Scientific Corp$33.7M0.69%0.02%Not reportedQ3 2018
CTNMContineum Therapeutics, Inc.$32.5M0.67%12.30%+65.2%Q2 2024
ZURAZura Bio Ltd$29.2M0.60%7.56%+1.7%Q2 2023
QUREuniQure N.V.$29.1M0.60%1.95%NewQ4 2025
PROKProkidney Corp.$27.6M0.57%Not reportedNot reportedQ3 2022
COHRCoherent Corp.$25.5M0.52%0.09%NewQ4 2025
CMGChipotle Mexican Grill Inc$25.4M0.52%0.05%Not reportedQ1 2020
AURAAura Biosciences, Inc.$23.8M0.49%6.88%Not reportedQ1 2025
TNGXTango Therapeutics, Inc.$23.6M0.48%1.96%NewQ4 2025
BIIBBiogen Inc.$23.3M0.48%0.09%-21.3%Q1 2020
Q3 2025Reported Nov 14, 202589 positions
ARQTArcutis Biotherapeutics, Inc.$198M5.06%8.71%-9.2%Q1 2023
BNTCBenitec Biopharma Inc.$139M3.55%37.62%Not reportedQ2 2021
METAMeta Platforms, Inc.$126M3.21%Not reported+0.7%Q4 2014
LEGNLegend Biotech Corp$125M3.19%1.04%+1.2%Q2 2020
ETNB89bio, Inc.$122M3.12%5.58%-41.7%Q1 2023
IMTXImmatics N.V.$102M2.62%9.90%Not reportedQ1 2024
KOCoca Cola Co$96.5M2.47%0.03%+18.0%Q1 2024
GEGeneral Electric Co$93.3M2.39%0.03%Not reportedQ2 2023
NVDANvidia Corp$90.2M2.31%0.00%-3.2%Q4 2022
EYPTEyePoint, Inc.$88.2M2.26%8.90%-9.0%Q1 2021
BHVNBiohaven Ltd.$84.4M2.16%5.31%Not reportedQ1 2022
MLYSMineralys Therapeutics, Inc.$80.9M2.07%2.70%+22.2%Q1 2025
HDHome Depot, Inc.$79.9M2.05%0.02%+50.9%Q4 2016
TSMTaiwan Semiconductor Manufacturing Co Ltd$77.4M1.98%0.00%-7.7%Q2 2023
KURAKura Oncology, Inc.$71.8M1.84%9.33%Not reportedQ3 2020
FERGFerguson Enterprises Inc.$68.8M1.76%0.16%+61.5%Q4 2023
AVBPArriVent BioPharma, Inc.$68.3M1.75%9.07%+8.5%Q1 2024
APLSApellis Pharmaceuticals, Inc.$65.1M1.67%2.28%Not reportedQ1 2020
AMDAdvanced Micro Devices Inc$64.5M1.65%0.02%Not reportedQ4 2022
ORCLOracle Corp$63.6M1.63%0.01%-1.9%Q4 2022
RAREUltragenyx Pharmaceutical Inc.$60.7M1.55%2.09%-11.4%Q4 2021
BACBank of America Corp$59.9M1.53%0.02%+25.1%Q1 2018
KALVKalVista Pharmaceuticals, Inc.$58.1M1.49%9.44%-3.8%Q1 2020
APOApollo Global Management, Inc.$57.5M1.47%0.07%+0.7%Q3 2023
MSFTMicrosoft Corp$56.7M1.45%0.00%+10.8%Q4 2015
PVLAPalvella Therapeutics, Inc.$51.6M1.32%7.42%+15.1%Q4 2024
COFCapital One Financial Corp$50.8M1.30%0.04%+23.0%Q4 2016
DHRDanaher Corp$50.7M1.30%0.04%+46.4%Q3 2014
RCUSArcus Biosciences, Inc.$50.2M1.28%3.44%Not reportedQ3 2023
FULCFulcrum Therapeutics, Inc.$49.5M1.27%9.94%+5.9%Q1 2021
CMPXCompass Therapeutics, Inc.$49.4M1.26%7.94%+97.2%Q2 2025
AMZNAmazon Com Inc$48M1.23%0.00%-15.2%Q1 2016
TSLATesla, Inc.$40.6M1.04%0.00%-1.2%Q2 2024
KDPKeurig Dr Pepper Inc.$40.1M1.03%0.12%Not reportedQ3 2024
BSXBoston Scientific Corp$34.5M0.88%0.02%Not reportedQ3 2018
UNHUnitedhealth Group Inc$33.2M0.85%0.01%+41.5%Q4 2016
RNAMAvidity Biosciences, Inc.$32.7M0.84%0.51%NewQ3 2025
ERASErasca, Inc.$31.6M0.81%5.11%Not reportedQ2 2024
INSMINSMED Inc$31.4M0.80%0.10%-8.8%Q1 2020
PROKProkidney Corp.$29.9M0.76%Not reportedNot reportedQ3 2022
CRMSalesforce, Inc.$29.7M0.76%0.01%Not reportedQ4 2016
DKSDick'S Sporting Goods, Inc.$28.5M0.73%0.14%-50.8%Q2 2025
AURAAura Biosciences, Inc.$27M0.69%6.94%Not reportedQ1 2025
GLUEMonte Rosa Therapeutics, Inc.$24.9M0.64%5.44%Not reportedQ2 2021
JNJJohnson & Johnson$24.6M0.63%0.01%Not reportedQ4 2019
ZURAZura Bio Ltd$23.7M0.61%8.42%+12.6%Q2 2023
BIIBBiogen Inc.$23.6M0.60%0.11%+10.7%Q1 2020
MRVLMarvell Technology, Inc.$22.9M0.59%0.03%Not reportedQ1 2023
NOWServiceNow, Inc.$20.2M0.52%0.01%Not reportedQ3 2019
CTNMContineum Therapeutics, Inc.$20.2M0.52%6.13%Not reportedQ2 2024
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.